Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 7
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Woo Baidal, Jennifer A. Locks, Lindsey M. Cheng, Erika R. Blake-Lamb, Tiffany L. Perkins, Meghan E. and Taveras, Elsie M. 2016. Risk Factors for Childhood Obesity in the First 1,000 Days. American Journal of Preventive Medicine, Vol. 50, Issue. 6, p. 761.


    De Long, Nicole E. Barry, Eric J. Pinelli, Christopher Wood, Geoffrey A. Hardy, Daniel B. Morrison, Katherine M. Taylor, Valerie H. Gerstein, Hertzel C. and Holloway, Alison C. 2015. Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats. Toxicology and Applied Pharmacology, Vol. 285, Issue. 1, p. 32.


    Grzeskowiak, LE Morrison, JL Henriksen, TB Bech, BH Obel, C Olsen, J and Pedersen, LH 2015. Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort. BJOG: An International Journal of Obstetrics & Gynaecology, p. n/a.


    Grzeskowiak, LE McBain, R Dekker, GA and Clifton, VL 2015. Antidepressant use in late gestation and risk of postpartum haemorrhage: a retrospective cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, p. n/a.


    Weisskopf, Etienne Fischer, Céline J Bickle Graz, Myriam Morisod Harari, Mathilde Tolsa, Jean-François Claris, Olivier Vial, Yvan Eap, Chin B Csajka, Chantal and Panchaud, Alice 2015. Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence. Expert Opinion on Drug Safety, Vol. 14, Issue. 3, p. 413.


    Wisner, Katherine L and Schaefer, Christof 2015. Drugs During Pregnancy and Lactation.


    Grzeskowiak, Luke E. Gilbert, Andrew L. Sørensen, Thorkild I.A. Olsen, Jørn Sørensen, Henrik T. Pedersen, Lars H. and Morrison, Janna L. 2013. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age. Annals of Epidemiology, Vol. 23, Issue. 11, p. 681.


    ×
  • Journal of Developmental Origins of Health and Disease, Volume 3, Issue 4
  • August 2012, pp. 253-261

Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight

  • L. E. Grzeskowiak (a1), A. L. Gilbert (a1) and J. L. Morrison (a2)
  • DOI: http://dx.doi.org/10.1017/S2040174411000808
  • Published online: 09 January 2012
Abstract

The objective was to investigate the association between prenatal selective serotonin reuptake inhibitor (SSRI) exposure and overweight in offspring at 4–5 years of age. We conducted a retrospective cohort study using linked records from the Women's and Children's Health Network in South Australia, Australia. Women were eligible to participate if they gave birth to singleton, live-born infants between September 2000 and December 2005. Women were excluded if they received a dispensing for an antidepressant other than SSRIs or an antipsychotic or an anti-epileptic or had a chronic medical condition. Of the 6560 eligible women, 71 received a dispensing for an SSRI (exposed), 204 had a reported psychiatric illness but did not receive a dispensing for any antidepressant (untreated psychiatric illness) and 6285 did not have a reported psychiatric illness and did not receive a dispensing for any antidepressant (unexposed). Childhood overweight was classified as a body mass index >85th percentile, based on age and sex. At 4–5 years of age, female offspring of exposed mothers were less likely to be overweight compared with female offspring of mothers with an untreated psychiatric illness [adjusted Prevalence Ratio (aPR) 0.23; 95% confidence interval (CI) 0.05–0.98] and female offspring of unexposed mothers (aPR 0.27; 0.07–0.99). No association with overweight was observed among male offspring of exposed mothers compared with male offspring of mothers with an untreated psychiatric illness (aPR 1.17; 0.54–2.51) and male offspring of unexposed mothers (aPR 0.93; 0.52–1.67). Further research is required to confirm these findings and examine the potential mechanisms behind the sex-specific differences.

Copyright
Corresponding author
*Address for Correspondence: Mr L. Grzeskowiak, Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, GPO Box 2471, Adelaide SA 5001, Australia. (Email grzly001@mymail.unisa.edu.au)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.G Emslie , R Judge . Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr Scand. 2000; 101 (Suppl 403), 26S34S.

4.SE Andrade , MA Raebel , J Brown , Use of antidepressant medications during pregnancy: a multisite study. Am J Ostet Gynecol. 2008; 198, 194.e191194.e195.

5.PS Masand , S Gupta . Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry. 1999; 7, 6984.

6.J Van Harten . Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmcokinet. 1993; 24, 203220.

7.LE Grzeskowiak , AL Gilbert , JL Morrison . Investigating outcomes following the use of SSRIs for treating depression in pregnancy: a focus on methodological issues. Drug Saf. 2011; 34, 10271048.

8.KA Lattimore , SM Donn , N Kaciroti , Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol. 2005; 25, 595604.

9.PM Whitaker-Azmitia . Serotonin and brain development: role in human developmental diseases. Brain Res Bull. 2001; 56, 479485.

10.JE Blundell , JCG Halford . Serotonin and appetite regulation: implications for the pharmacological treatment of obesity. CNS Drugs. 1998; 9, 473495.

11.JC Halford , JA Harrold , CL Lawton , JE Blundell . Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr Drug Targets. 2005; 6, 201213.

12.BJ Sargent , AJ Henderson . Targeting 5-HT receptors for the treatment of obesity. Curr Opin Pharmacol. 2011; 11, 5258.

13.Q Li , CH Wichems , L Ma , Brain region specific alterations of 5 HT2A and 5 HT2C receptors in serotonin transporter knockout mice. J Neurochem. 2003; 84, 12561265.

15.S Bouali , A Evrard , M Chastanet , Sex hormone dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur J Neurosci. 2003; 18, 22032212.

16.SJ Line , C Barkus , C Coyle , Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice. Eur Neuropsychopharmacol. 2011; 21, 108116.

17.N Üçeyler , M Schütt , F Palm , Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. Int J Obes. 2010; 34, 701711.

18.SFS Lisboa , PE Oliveira , LC Costa , EJ Venancio , EG Moreira . Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology. 2007; 80, 4956.

19.TF Oberlander , JA Gingrich , MS Ansorge . Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009; 86, 672677.

20.CD Chambers , PO Anderson , RG Thomas , Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics. 1999; 104, e61e66.

21.P Merlob , B Stahl , J Sulkes . Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. Eur J Pediatr. 2004; 163, 135139.

22.M Moretti , A Sharma , B Bar-Oz , G Koren , S Ito . Fluoxetine and its effects on the nursing infant: a prospective cohort study [Abstract]. Clin Pharmacol Ther. 1999; 65, 141.

23.V Hendrick , LM Smith , S Hwang , LL Altshuler , D Haynes . Weight gain in breastfed infants of mothers taking antidepressant medications. J Clin Psychiatry. 2003; 64, 410412.

24.AJ Lewis , M Galbally , G Opie , A Buist . Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry. 2010; 44, 482487.

25.LE Grzeskowiak , AL Gilbert , JL Morrison . Hospital pharmacy dispensing records for pharmacoepidemiology research into late gestation exposure to antidepressants. J Pharm Pract Res. 2010; 40, 265268.

26.TJ Cole , MC Bellizzi , KM Flegal , WH Dietz . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000; 320, 12401245.

29.EM Blair , Y Liu , NH De Klerk , DM Lawrence . Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database. BMC Pediatr. 2005; 5, 13.

31.S Greenland . Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case–control studies. Am J Epidemiol. 2004; 160, 301305.

32.TS Olds , GR Tomkinson , KE Ferrar , CA Maher . Trends in the prevalence of childhood overweight and obesity in Australia between 1985 and 2008. Int J Obes. 2010; 34, 5766.

33.H Jovanovic , J Lundberg , P Karlsson , Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage. 2008; 39, 14081419.

34.KP Cosgrove , CM Mazure , JK Staley . Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007; 62, 847855.

35.VK Yadav , F Oury , N Suda , A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell. 2009; 138, 976989.

36.M Collin , M Bäckberg , K Önnestam , B Meister . 5-HT1A receptor immunoreactivity in hypothalamic neurons involved in body weight control. Neuroreport. 2002; 13, 945951.

37.P Hutson , C Dourish , G Curzon . Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol. 1988; 150, 361366.

39.Y Qu , N Villacreses , DL Murphy , SI Rapoport . 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology. 2005; 180, 1220.

40.P Moya , M Fox , C Jensen , Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. BMC Pharmacol. 2011; 11, 3.

41.J Li , J Olsen , M Vestergaard , C Obel , JL Baker , Prenatal stress exposure related to maternal bereavement and risk of childhood overweight. PLoS One. 2010; 5, e11896.

42.L Colvin , L Slack Smith , FJ Stanley , C Bower . Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol. 2011; 91, 142152.

43.MK Bakker , P Kolling , PB van den Berg , HEK de Walle , LTW de Jong van den Berg . Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol Apr. 2008; 65, 600606.

44.S Alwan , J Reefhuis , SA Rasmussen , JM Friedman . Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol. 2011; 51, 264270.

45.B Kallen . Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004; 158, 312316.

46.TF Oberlander , W Warburton , S Misri , J Aghajanian , C Hertzman . Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006; 63, 898906.

47.CD Chambers , KA Johnson , LM Dick , RJ Felix , KL Jones . Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996; 335, 10101015.

48.TF Oberlander , W Warburton , S Misri , J Aghajanian , C Hertzman . Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry. 2008; 192, 338343.

49.H Malm , T Klaukka , PJ Neuvonen . Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol. 2005; 106, 12891296.

50.KA Ertel , KC Koenen , JW Rich-Edwards , MW Gillman , L Myer . Maternal depressive symptoms not associated with reduced height in young children in a US prospective cohort study. PLoS One. 2010; 5, e13656.

51.LM Barnett , E Van Beurden , PJ Morgan , LO Brooks , J Beard . Childhood motor skill proficiency as a predictor of adolescent physical activity. J Adolesc Health. 2009; 44, 252259.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Developmental Origins of Health and Disease
  • ISSN: 2040-1744
  • EISSN: 2040-1752
  • URL: /core/journals/journal-of-developmental-origins-of-health-and-disease
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: